Skip to main content

Lung Cancer HELPLine 833-797-5800

LUNGevity.org

Navigating EGFR

Lung Cancer HELPLine 833-797-5800

Visit our other Patient Gateways  

Main navigation

  • About EGFR-Positive Lung Cancer
  • Find a Specialist
  • Learn About Clinical Trials
  • Find Your Community
  • News and Events
  • Library

Main navigation

  • EGFR
    • About EGFR-Positive Lung Cancer
    • Find a Specialist
    • Learn About Clinical Trials
    • Find Your Community
    • News and Events
    • Library

EGFR

Video Library

  • Background showing DNA

    Article

    May 03, 2023

    A Survivor’s Experience with Biomarker Testing and TKI Treatments

    Back in 2013, when Dan Cadigan was first diagnosed with stage III lung cancer, his treatment options were limited to surgery followed by chemotherapy. However, at his one-year...
    READ MORE about A Survivor’s Experience with Biomarker Testing and TKI Treatments ›
  • Aimee Yairi with her father

    Article

    May 03, 2023

    Being a Caregiver for a Parent

    Being a caregiver for a parent means helping in different ways and playing different roles. For Aimee Yairi, it started when her dad told her that he was having a lingering cough...
    READ MORE about Being a Caregiver for a Parent ›
  • Neal Augenstein smiling with blog title

    Video

    May 03, 2023

    Beloved Reporter Goes Public with His Lung Cancer Diagnosis

    A familiar voice to many in the greater Washington, DC area, Neal Augenstein, a beloved reporter at WTOP radio, joined fellow lung cancer survivor Melinda Ojermark to discuss his...
    READ MORE about Beloved Reporter Goes Public with His Lung Cancer Diagnosis ›
  • Depiction of coronavirus

    Article

    May 02, 2023

    What the End of the COVID Public Health Emergency Means for You

    It’s been more than 3 years since the US Department of Health and Human Services (HHS) first declared a nationwide Public Health Emergency (PHE) due to COVID-19. Since then...
    READ MORE about What the End of the COVID Public Health Emergency Means for You ›
  • Cover image for blog post

    Article

    April 25, 2023

    Joanne G. Shares her Story

    My lung cancer journey began back in February 2021, by happenstance. I didn’t have any of the classic symptoms, other than I didn’t feel well and I was unusually tired. I...
    READ MORE about Joanne G. Shares her Story ›
  • Information about HOPE Summit along with a photo

    Article

    April 12, 2023

    10 Reasons to Attend LUNGevity’s HOPE Summit

    HOPE Summit is a weekend conference unlike any other! The Summit brings hundreds of people affected by lung cancer together to build their community, give and get support, and...
    READ MORE about 10 Reasons to Attend LUNGevity’s HOPE Summit ›
  • Cancer Grand Challenges graphic

    Article

    April 05, 2023

    Tackling the Biggest Challenges in Cancer

    Cancer Grand Challenges is a partnership between Cancer Research UK (CRUK) and the National Cancer Institute (NCI), which funds global teams of leading researchers across various...
    READ MORE about Tackling the Biggest Challenges in Cancer ›
  • Let Your Voice Be Heard!

    Article

    March 21, 2023

    Let Your Voice Be Heard!

    We are collecting stories from patients, caregivers, friends, and family members! Tell us how lung cancer has affected your life. Email your story to us at support@lungevity.org...
    READ MORE about Let Your Voice Be Heard! ›
  • Clinical trials graphic

    Article

    March 21, 2023

    Finding Clinical Trials for Lung Cancer: Tools and Resources

    Clinical trials are an important option for patients because the newest treatment approaches, not available otherwise, are being tested in them. Clinical trial research leads to...
    READ MORE about Finding Clinical Trials for Lung Cancer: Tools and Resources ›
  • Cover screen for video

    Video

    March 15, 2023

    RET, MET, and EGFR: An unusual tale of three oncogenes in lung cancer

    LUNGevity's Upal Basu Roy, PhD, MPH, Executive Director, Research, discusses innovative research into RET+ NSCLC with patient advocates and the scientist conducting the studies...
    READ MORE about RET, MET, and EGFR: An unusual tale of three oncogenes in lung cancer ›
  • Cover images for nutrition webinar

    Video

    March 14, 2023

    Fuel for the Future: Good Nutrition for the Lung Cancer Community

    Learn valuable information about good nutrition that can help you live well through lung cancer treatment and beyond. Gain insight and tips from Oncology Dietitian Lori Bumbaco, MS...
    READ MORE about Fuel for the Future: Good Nutrition for the Lung Cancer Community ›
  • Logo for the targeted therapies of lung cancer meeting

    Article

    March 09, 2023

    Real-World Drug Development at the Targeted Therapies of Lung Cancer Meeting

    The development of new treatments for any disease relies on the collaborative efforts of many different stakeholders, such as scientists, clinicians, patient advocacy groups...
    READ MORE about Real-World Drug Development at the Targeted Therapies of Lung Cancer Meeting ›

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »

You are about to leave the Patient Gateway

You’re one click away from learning about one of our most valued sponsors. Read about how they’re making a difference in patients’ lives.

ProceedCancel

SHARE

The Patient Gateways are a project of LUNGevity Foundation, an organization transforming how people are diagnosed and live with lung cancer. Learn more here.

Privacy policy | Contact us

 

This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.

 

Copyright © 2025 LUNGevity Foundation. All rights reserved.